By some estimates, nearly half of the world's population suffers from a sleep disorder of some kind. Whether it be sleep ...

An expert discusses treatments for narcolepsy, comparing options for managing excessive daytime sleepiness (EDS) and cataplexy, and examines the advantages, limitations, and clinical scenarios for ...

THEY were the super-cool teens that lived in a warehouse – but what are the cast of Heartbreak High up to now? The Australian ...

Feb. 19, 2025, 17 states involved in a complaint against Section 504 of the Rehabilitation Act, which has been stayed, filed ...

Jim Justice was so proud of the Roads to Prosperity bond issue that, in a display of astonishing tone-deafness, on repeated occasions he called for making the day voters approved ...

Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its target price increased by equities research analysts at HC ...

Dogs may look adorable when they snooze, but their sleeping habits actually hold fascinating clues on how living with humans ...

Despite the regulatory setback, analysts appear optimistic, noting that Harmony’s long-term prospects remain bright given the ...

Harmony Biosciences' FDA setback for pitolisant in idiopathic hypersomnia doesn't impact its 2025 revenue outlook, with a ...

Harmony Biosciences is facing more of a nightmare than sweet dreams on the road to securing a new use for its excessive ...